A detailed history of Arrowstreet Capital, Limited Partnership transactions in Boston Scientific Corp stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 4,901,806 shares of BSX stock, worth $377 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
4,901,806
Previous 6,047,814 18.95%
Holding current value
$377 Million
Previous $350 Million 3.98%
% of portfolio
0.31%
Previous 0.37%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $66 Million - $78.6 Million
-1,146,008 Reduced 18.95%
4,901,806 $336 Million
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $77.3 Million - $91.9 Million
-1,589,034 Reduced 20.81%
6,047,814 $350 Million
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $63.1 Million - $68.8 Million
-1,258,037 Reduced 14.14%
7,636,848 $403 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $18 Million - $19.8 Million
362,495 Added 4.25%
8,894,885 $481 Million
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $2.32 Million - $2.57 Million
51,412 Added 0.61%
8,532,390 $427 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $25.1 Million - $29.9 Million
633,546 Added 8.07%
8,480,978 $392 Million
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $11.3 Million - $33.8 Million
307,805 Added 4.08%
7,847,432 $304 Million
Q2 2022

Aug 15, 2022

BUY
$35.24 - $47.1 $74.3 Million - $99.3 Million
2,108,813 Added 38.83%
7,539,627 $281 Million
Q1 2022

May 13, 2022

BUY
$40.9 - $45.1 $88.3 Million - $97.3 Million
2,157,849 Added 65.93%
5,430,814 $241 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $91 Million - $107 Million
2,391,242 Added 271.2%
3,272,965 $139 Million
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $35.1 Million - $39.1 Million
851,823 Added 2848.91%
881,723 $38.3 Million
Q2 2021

Aug 13, 2021

BUY
$38.58 - $44.24 $1.15 Million - $1.32 Million
29,900 New
29,900 $1.28 Million
Q1 2021

May 14, 2021

SELL
$35.27 - $39.67 $8.57 Million - $9.64 Million
-242,898 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$33.15 - $41.97 $7.76 Million - $9.83 Million
234,198 Added 2691.93%
242,898 $8.73 Million
Q3 2020

Nov 12, 2020

SELL
$34.44 - $42.23 $2.56 Million - $3.14 Million
-74,324 Reduced 89.52%
8,700 $332,000
Q2 2020

Aug 12, 2020

SELL
$30.19 - $39.11 $58.3 Million - $75.5 Million
-1,930,502 Reduced 95.88%
83,024 $2.92 Million
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $52 Million - $92 Million
2,013,526 New
2,013,526 $65.7 Million
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $219,932 - $270,774
-6,300 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$32.91 - $40.75 $141,512 - $175,225
-4,300 Reduced 40.57%
6,300 $242,000
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $336,338 - $413,824
10,600 New
10,600 $375,000
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $23.6 Million - $30.1 Million
-878,175 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$25.2 - $28.54 $158 Million - $179 Million
-6,271,672 Reduced 87.72%
878,175 $24 Million
Q4 2017

Feb 09, 2018

BUY
$24.79 - $29.8 $140 Million - $168 Million
5,633,721 Added 371.59%
7,149,847 $177 Million
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $39.8 Million - $44.2 Million
1,516,126
1,516,126 $44.2 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $110B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.